Your browser doesn't support javascript.
loading
Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
Ma, Linlin; Zhu, Min; Li, Guanghui; Gai, Junwei; Li, Yanfei; Gu, Huaiyu; Qiao, Peng; Li, Xiaofei; Ji, Weiwei; Zhao, Rui; Wu, Yue; Wan, Yakun.
Afiliação
  • Ma L; School of Medical Technology, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Zhu M; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Li G; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Gai J; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Li Y; School of Medical Technology, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Gu H; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Qiao P; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Li X; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Ji W; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China.
  • Zhao R; Shanghai Donghai Geriatric Nursing Hospital, Shanghai, China.
  • Wu Y; School of Medical Technology, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Wan Y; Shanghai Novamab Biopharmaceuticals Co., Ltd., Shanghai, China. ywansystemsbiology@163.com.
Respir Res ; 23(1): 316, 2022 Nov 19.
Article em En | MEDLINE | ID: mdl-36403040

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma Limite: Animals Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma Limite: Animals Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido